Literature DB >> 27803232

Surveillance of intramedullary cartilage tumours in long bones.

V Sampath Kumar1, P N M Tyrrell1, J Singh1, J Gregory1, G L Cribb1, P Cool1.   

Abstract

AIMS: The purpose of this study was to determine if clinical and radiological surveillance of cartilage tumours with low biological activity is appropriate. PATIENTS AND METHODS: A total of 98 patients with an intramedullary cartilage neoplasm in a long bone met our inclusion criteria and were included in the study. These patients had undergone a total of 384 scans. Patients with radiological follow-up of more than three years (46 patients) were divided into two groups: an active group (11 patients) and a latent group (35 patients).
RESULTS: Active lesions had a total growth in all three planes that was > 6 mm, whilst latent lesions had < 6 mm of growth. Most latent lesions were heavily calcified: active lesions were calcified less than 50% (p = 0.025).
CONCLUSION: Clinico-radiological surveillance can identify growing cartilage lesions: MRI is the surveillance modality of choice. A CT scan is recommended, in addition, at presentation to assess the amount of calcification within the lesion. A first follow-up MRI is suggested one year from diagnosis. If the total growth in the cartilage lesion is > 6 mm, surgical treatment should be considered. Otherwise, a second surveillance scan can be performed at three years to determine further management. Cite this article: Bone Joint J 2016;98-B:1542-7. ©2016 The British Editorial Society of Bone & Joint Surgery.

Entities:  

Keywords:  Chondroid lesion; Enchondroma; Follow-up; Intramedullary cartilage tumour; Long bone; MRI; Surveillance

Mesh:

Year:  2016        PMID: 27803232     DOI: 10.1302/0301-620X.98B11.37864

Source DB:  PubMed          Journal:  Bone Joint J        ISSN: 2049-4394            Impact factor:   5.082


  7 in total

1.  Radiographic Enchondroma Surveillance: Assessing Clinical Outcomes and Costs Effectiveness.

Authors:  Craig C Akoh; Ethan Craig; Alexander M Troester; Benjamin J Miller
Journal:  Iowa Orthop J       Date:  2019

2.  Solitary bone tumor imaging reporting and data system (BTI-RADS): initial assessment of a systematic imaging evaluation and comprehensive reporting method.

Authors:  Guilherme Jaquet Ribeiro; Romain Gillet; Gabriela Hossu; Jean-Michel Trinh; Eve Euxibie; François Sirveaux; Alain Blum; Pedro Augusto Gondim Teixeira
Journal:  Eur Radiol       Date:  2021-03-25       Impact factor: 5.315

3.  Magnetic resonance imaging follow-up of chondroid tumors: regression vs. progression.

Authors:  Bo Mi Chung; Sung Hwan Hong; Hye Jin Yoo; Ja-Young Choi; Hee-Dong Chae; Dong Hyun Kim
Journal:  Skeletal Radiol       Date:  2017-12-03       Impact factor: 2.199

4.  The changing face of central chondrosarcoma of bone. One UK-based orthopaedic oncology unit's experience of 33 years referrals.

Authors:  A Mark Davies; Anish Patel; Rajesh Botchu; Christine Azzopardi; Steven James; Lee Jeys
Journal:  J Clin Orthop Trauma       Date:  2021-02-27

5.  Surgical therapy of benign and low-grade malignant intramedullary chondroid lesions of the distal femur: intralesional resection and bone cement filling with or without osteosynthesis.

Authors:  Georg W Omlor; Vera Lohnherr; Pit Hetto; Simone Gantz; Jörg Fellenberg; Christian Merle; Thorsten Guehring; Burkhard Lehner
Journal:  Strategies Trauma Limb Reconstr       Date:  2018-11-03

6.  Unrecognized Chondrosarcoma as a Cause of Total Hip Arthroplasty Failure.

Authors:  Laurent Mustaki; Patrick Goetti; Nicolas Gallusser; Boris Morattel; Hannes A Rüdiger; Stéphane Cherix
Journal:  Arthroplast Today       Date:  2021-01-11

7.  Can MRI differentiate between atypical cartilaginous tumors and high-grade chondrosarcoma? A systematic review.

Authors:  Claudia Deckers; Maarten J Steyvers; Gerjon Hannink; H W Bart Schreuder; Jacky W J de Rooy; Ingrid C M Van Der Geest
Journal:  Acta Orthop       Date:  2020-05-20       Impact factor: 3.717

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.